124 filings
Page 6 of 7
DRS
yrj2o
24 Nov 20
Draft registration statement
12:00am
8-K
jdtp412a ot
12 Nov 20
ALX Oncology Reports Third Quarter 2020 Financial Results and Provides Clinical Development and Operational Highlights
4:20pm
10-Q
7zmprn0gi01ua i5qv
27 Aug 20
Quarterly report
4:49pm
8-K
uqd9fcyp
27 Aug 20
ALX Oncology Reports Second Quarter 2020 Financial Results and Provides Operational and Clinical Highlights
4:16pm
8-K
4iku r9mvz53
21 Jul 20
ALX Oncology Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
4:02pm
S-8
1uai5ba
17 Jul 20
Registration of securities for employees
4:46pm
424B4
tr6q5xckbwly
17 Jul 20
Prospectus supplement with pricing info
4:27pm
EFFECT
60g8ioshj
17 Jul 20
Notice of effectiveness
12:15am
S-1MEF
zze5 x1yd
16 Jul 20
Registration of additional securities for an S-1
8:08pm
CERT
1xcs5xr7cnh9 zg
16 Jul 20
Certification of approval for exchange listing
3:09pm
CORRESP
bdfjf6nl9h1ffu6f
14 Jul 20
Correspondence with SEC
12:00am
CORRESP
4wpes27
14 Jul 20
Correspondence with SEC
12:00am
8-A12B
ccqel vjzs2
13 Jul 20
Registration of securities on exchange
4:12pm
S-1/A
jtylibh m2163d6ct
13 Jul 20
IPO registration (amended)
7:26am
CORRESP
t7k6bbxrmfhtg71
2 Jul 20
Correspondence with SEC
12:00am
S-1
hlkjmn 5v71k9lv
26 Jun 20
IPO registration
4:34pm
CORRESP
3tdgvgrbgh
26 Jun 20
Correspondence with SEC
12:00am
UPLOAD
m8o5v5cq64ou po5
24 Jun 20
Letter from SEC
12:00am
DRS/A
k920to39 lxfdd6
12 Jun 20
Draft registration statement (amended)
12:00am